Select Medical (NYSE:SEM) Issues FY 2021 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided EPS guidance of 2.410-2.580 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.310. The company issued revenue guidance of $5.70 billion-$5.90 billion, compared to the consensus revenue estimate of $5.79 billion.

SEM stock traded up $0.31 during mid-day trading on Friday, reaching $37.39. 351,344 shares of the stock traded hands, compared to its average volume of 672,701. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 2.78. Select Medical has a 52-week low of $13.51 and a 52-week high of $39.76. The company has a market cap of $5.04 billion, a P/E ratio of 23.37, a P/E/G ratio of 1.28 and a beta of 1.47. The stock’s fifty day moving average is $36.05 and its 200-day moving average is $29.82.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, May 6th. The health services provider reported $0.82 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.17. Select Medical had a net margin of 3.93% and a return on equity of 20.22%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the firm earned $0.37 earnings per share. The business’s quarterly revenue was up 9.3% on a year-over-year basis. Equities research analysts expect that Select Medical will post 1.56 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 1st. Stockholders of record on Wednesday, May 19th will be given a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.34%. This is a positive change from Select Medical’s previous quarterly dividend of $0.10. The ex-dividend date is Tuesday, May 18th.

A number of analysts have recently issued reports on SEM shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of Select Medical from $42.00 to $46.00 and gave the stock a buy rating in a research report on Monday, May 10th. Zacks Investment Research lowered shares of Select Medical from a strong-buy rating to a hold rating and set a $40.00 price target for the company. in a research report on Monday, May 3rd. Credit Suisse Group increased their price target on shares of Select Medical from $32.00 to $34.00 and gave the stock a neutral rating in a research report on Monday, March 8th. Bank of America raised shares of Select Medical from an underperform rating to a buy rating and increased their price target for the stock from $30.00 to $36.00 in a research report on Friday, February 26th. Finally, Benchmark increased their price objective on Select Medical from $40.00 to $44.00 and gave the stock a buy rating in a report on Thursday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $40.00.

In other Select Medical news, VP Robert G. Breighner, Jr. sold 5,040 shares of the stock in a transaction that occurred on Monday, May 10th. The stock was sold at an average price of $37.07, for a total transaction of $186,832.80. Following the transaction, the vice president now owns 33,018 shares in the company, valued at $1,223,977.26. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director James S. Ely III sold 20,000 shares of the stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $35.02, for a total value of $700,400.00. Insiders sold 419,431 shares of company stock worth $13,849,167 in the last 90 days. 19.70% of the stock is currently owned by corporate insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.

Further Reading: What Does a Sell-Side Analyst Rating Mean?

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.